Skip to main content

A33 (Oxybutynin Chloride Extended-Release 15 mg)

Pill with imprint A33 is White, Round and has been identified as Oxybutynin Chloride Extended-Release 15 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.

Oxybutynin is used in the treatment of urinary frequency; urinary incontinence; neurogenic detrusor overactivity; dysuria and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A33

Oxybutynin chloride extended-release 15 mg A33
Oxybutynin chloride extended-release 15 mg A33
Oxybutynin chloride extended-release 15 mg A33

Oxybutynin Chloride Extended-Release

Imprint
A33
Strength
15 mg
Color
White
Shape
Round
Availability
Rx and/or OTC
Drug Class
Urinary antispasmodics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals of New York, LLC
Inactive Ingredients
methacrylic acid - ethyl acrylate copolymer (1:1) type a, hydrogenated cottonseed oil, hypromelloses, isopropyl alcohol, lactose monohydrate, microcrystalline cellulose, magnesium silicate, triethyl citrate, polysorbate 80, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
65162-0373 Amneal Pharmaceuticals LLC
10135-0611 Marlex Pharmaceuticals Inc.

Get help with Imprint Code FAQs.

Related images for "A33"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.